Search Results 1211-1220 of 17848 for Assay

1. Researchers explore whether senescence-associated secretory phenotype (SASP) is a potential driver of age-related dysfunction - Mayo Clinic

   A Mayo Clinic study suggests that senescence-associated secretory phenotype (SASP) proteins could help identify people at risk of functional decline and ...

2. Alzheimer's Disease Clinical Trials - Mayo Clinic Research

   The purpose of this study is to validate the Alzheimer Disease Biomarkers assays (Phospho-Tau/Total-Tau/Ab42) being implemented at Mayo to compare them to the ...

3. A Study of an Implantable System for Remodulin Post Approval - Mayo Clinic

   Inclusion Criteria: Subject or legally authorized representative provides written authorization and/or consent per institution and geographical requirements ...

4. S1400 Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer - Mayo Clinic

   ... assays in clinical practice, 2) have cluster of differentiation (CD)4 count >= 400/mcL, 3) not require prophylaxis for any opportunistic infections (i.e. ...

5. Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer - Mayo Clinic

   ... assays prior to enrollment; For patients with unknown hepatitis C virus ribonucleic acid (HCV RNA) status, must be tested during study screening; patients ...

6. Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) - Mayo Clinic

   HbA1C > % (75 mmol/mol), as assessed using NGSP certified method and standardized to DCCT assay. Fasting Plasma Glucose > 270 mg/dL (15 mmol/L). Fasting ...

7. Cancer Treatment Clinical Trials - Mayo Clinic Research

   Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol Scottsdale/Phoenix, AZ; Rochester, MN. The major purpose of this ...

8. Gastroenterology and Hepatology - Clinical trials

   [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

9. A Study to Evaluate Precision Pharmacogenomics in Cancer Patients - Mayo Clinic

   About this study. THe purpose of this study is to examine the current and (potential) future therapeutic relevance of pharmacogenomics (PGx) testing for a ...

10. Olaparib and Cediranib Maleate in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

    ... assay with other high-grade histologies are also eligible. Due to the long acceptance of BRCA testing through Myriad, Myriad testing will be accepted as ...